- Recent Funding
- Investors
- Project X
Project X portfolio
Project X has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Synchron's $75M Series B+ round in December 2022, alongside University of Melbourne, Subversive Capital, Shanda Group and 6 others. That company is in Health and bio.
What Project X invests in
- Health and bio · 1 · 100%
- Robotics and hardware · 1 · 100%
- Manufacturing and industrial · 1 · 100%
How Project X invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $75M |
Share is of the 1 round on Recent Funding that name Project X. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Project X portfolio companies
| Company | Round with Project X | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $75M | $600M | Jun 29, 2026 Series B+ |
Most frequent co-investors
KKhosla Ventures1 shared round · last Dec 15, 2022
MMoore Strategic Ventures1 shared round · last Dec 15, 2022
- UUniversity of Melbourne1 shared round · last Dec 15, 2022
- NNeurotechnology Investors1 shared round · last Dec 15, 2022
- MMETIS innovative1 shared round · last Dec 15, 2022
- SSubversive Capital1 shared round · last Dec 15, 2022
- SShanda Group1 shared round · last Dec 15, 2022
IID8 Investments1 shared round · last Dec 15, 2022
- RReliance Industries1 shared round · last Dec 15, 2022
Similar investors
AAccelia Capital1 company · 1 deal in 12 mo
AAngel Academe1 company · 1 deal in 12 mo
BBioGenerator Ventures1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moDDeepWork Capital1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Project X, which is a subset of its real portfolio. API: /api/v1/investors/project-x (get a free API key). More: the most active VC firms and new venture capital funds.